The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study

BACKGROUND: New treatment modalities have not been widely adopted for patients with glioblastoma (GBM) after the addition of temozolomide to radiotherapy. We hypothesize that increased extent of resection (EOR) has resulted in improved survival for surgically treated patients with glioblastoma at th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendoza Mireles, Eduardo Erasmo, Skaga, Erlend, Server, Andres, Leske, Henning, Brandal, Petter, Helseth, Eirik, Rønning, Pål A, Vik-Mo, Einar O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666813/
https://www.ncbi.nlm.nih.gov/pubmed/38026582
http://dx.doi.org/10.1093/nop/npad037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666813/
https://www.ncbi.nlm.nih.gov/pubmed/38026582
http://dx.doi.org/10.1093/nop/npad037

Ejemplares similares